The FDA’s accelerated drug approval program is failing to protect cancer patients
Science-Based Medicine,
Drug approval is a process that should be and, for the most part, is rooted in rigorous science. However, there is always a…
Drug approval is a process that should be and, for the most part, is rooted in rigorous science. However, there is always a…
By CHADI NABHAN MD…
In clinical research, there is widespread acceptance that surrogate endpoints might not translate into long-term benefits (e.g.
By Ameet Sarpatwari, Michael S. Sinha, and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics…